Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis

INTRODUCTION: Besides their blood pressure-lowering effects, olmesartan medoxomil and amlodipine besylate exhibit additional anti-inflammatory mechanisms in atherosclerosic disease. Most of the studies investigating the effects of atherosclerosis focused on early atherosclerotic lesions, whereas les...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Des Devel Ther
Hoofdauteurs: Sievers, Philipp, Uhlmann, Lorenz, Korkmaz-Icöz, Sevil, Fastner, Christian, Bea, Florian, Blessing, Erwin, Katus, Hugo A, Preusch, Michael R
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2015
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524379/
https://ncbi.nlm.nih.gov/pubmed/26251572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S85203
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items